Showing results (11-20 of 645) with videos related to

Sort By:
Pageof 65
Clinical Advances in Hematology & Oncology : H&O|June 13, 2019
Bruton tyrosine kinase inhibitors for the treatment of mantle cell lymphoma: review of current evidence and future directionsDavid A Bond, Lapo Alinari, Kami Maddocks
Psychology & Health|March 17, 2016
The relation of illness perceptions to stress, depression, and fatigue in patients with chronic lymphocytic leukaemiaTravis D Westbrook, Kami Maddocks, Barbara L Andersen
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|March 26, 2021
Incorporating Novel Targeted and Immunotherapeutic Agents in Treatment of B-Cell LymphomasHarsh Shah, Deborah Stephens, John Seymour, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 9, 2015
Evaluation of incidence and risk factors for high-dose methotrexate-induced nephrotoxicityTracy Wiczer, Emily Dotson, Amy Tuten, et al.
ACG Case Reports Journal|May 25, 2026
Waldenstrom Macroglobulinemia Leading to Cholestatic Liver Injury and Rapid Progression to Liver FailureHannah Chi, David Kim, Gavisha Waidyaratne, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 1, 2024
Brentuximab Vedotin Plus Ibrutinib in Relapsed and Refractory Hodgkin LymphomaMatthew Mei, Ni-Chun Tsai, Joycelynne Palmer, et al.
Blood|January 30, 2019
A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphomaPeter Martin, Nancy L Bartlett, Kristie A Blum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2022
Treatment Outcomes and Roles of Transplantation and Maintenance Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma: Results From Large Real-World CohortsPeter Martin, Jonathon B Cohen, Michael Wang, et al.
Pageof 65